MMB inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents, resulting in increased iron availability for erythropoiesis, which can potentially improve anemia [47]. This evidence concerns the gene ACVR1 and anemia (phenotype).